1-6 of 6
Tsila Zuckerman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial eligibility, treatment patterns and outcome for venetoclax-based therapy in AML: a prospective cohort study

Clinical Trials & Observations
Ofir Wolach, Itai Levi, Boaz Nachmias, Sigal Tavor, irina Amitai, Yishai Ofran, Chezi Ganzel, Tsila Zuckerman, Doaa Okasha, Ilana Hellmann, Tamar Tadmor, Najib Dally, Jonathan Canaani, Galia Stemer, Moshe Grunspan, Adi Jacob Berger, Neta Frankel, Jenia Berelovich, Alexandra Bleterman, Moran Barak, Raanan Cohen, Yakir Moshe
Journal: Blood Advances
Blood Adv bloodadvances.2024014014.
https://doi.org/10.1182/bloodadvances.2024014014
Published: 2024
Includes: Supplemental data
Journal Articles

Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study

Clinical Trials & Observations
Jessica K. Altman, Tsila Zuckerman, Jamie Koprivnikar, James McCloskey, Vamsi Kota, Michael Keng, Olga Frankfurt, Yasmin Abaza, Dale L. Bixby, Ashkan Emadi, Micah Burch, Bhavana Bhatnagar, Selina M. Luger, Mary-Elizabeth Percival, Ofir Wolach, Michael Craig, Chezi Ganzel, Gail Roboz, Itai Levi, Anna Gourevitch, Liat Flaishon, Shoshi Tessler, Chen Blumberg, Stela Gengrinovitch, Ruth Ben Yakar, Jacob M. Rowe
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7494–7500.
https://doi.org/10.1182/bloodadvances.2023010943
Published: 2023
Journal Articles

Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis

Clinical Trials & Observations
Adi Eshel, Itai Sharon, Arnon Nagler, David Bomze, Ivetta Danylesko, Joshua A. Fein, Mika Geva, Israel Henig, Avichai Shimoni, Tsila Zuckerman, Ilan Youngster, Omry Koren, Roni Shouval
Journal: Blood Advances
Blood Adv (2022) 6 (2): 568–573.
https://doi.org/10.1182/bloodadvances.2021005110
Published: 2022
Includes: Supplemental data
Journal Articles

Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III

Clinical Trials & Observations
Shahrzad Bakhtiar, Emilia Salzmann-Manrique, Henric-Jan Blok, Dirk-Jan Eikema, Sheree Hazelaar, Mouhab Ayas, Amos Toren, Gal Goldstein, Despina Moshous, Franco Locatelli, Pietro Merli, Gerard Michel, Gülyüz Öztürk, Ansgar Schulz, Carsten Heilmann, Marianne Ifversen, Rob F. Wynn, Olga Aleinikova, Yves Bertrand, Abdelghani Tbakhi, Paul Veys, Musa Karakukcu, Alphan Kupesiz, Ardeshir Ghavamzadeh, Rupert Handgretinger, Emel Unal, Antonio Perez-Martinez, Muge Gokce, Fulvio Porta, Tekin Aksu, Gülsün Karasu, Isabel Badell, Per Ljungman, Elena Skorobogatova, Akif Yesilipek, Tsila Zuckerman, Robbert R. G. Bredius, Polina Stepensky, Bella Shadur, Mary Slatter, Andrew R. Gennery, Michael H. Albert, Peter Bader, Arjan Lankester
Journal: Blood Advances
Blood Adv (2021) 5 (1): 262–273.
https://doi.org/10.1182/bloodadvances.2020002185
Published: 2021
Includes: Supplemental data
Journal Articles

Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study

Clinical Trials & Observations
Moshe Yeshurun, Uri Rozovski, Oren Pasvolsky, Ofir Wolach, Ron Ram, Odelia Amit, Tsila Zuckerman, Anat Pek, Maly Rubinstein, Michal Sela-Navon, Pia Raanani, Liat Shargian-Alon
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3822–3828.
https://doi.org/10.1182/bloodadvances.2020002039
Published: 2020
Journal Articles

BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study

Clinical Trials & Observations
Tsila Zuckerman, Ron Ram, Luiza Akria, Maya Koren-Michowitz, Ron Hoffman, Israel Henig, Noa Lavi, Yishai Ofran, Netanel A. Horowitz, Olga Nudelman, Sigal Tavor, Shay Yeganeh, Stela Gengrinovitch, Liat Flaishon, Shoshi Tessler, Ruth Ben Yakar, Jacob M. Rowe
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3740–3749.
https://doi.org/10.1182/bloodadvances.2019000468
Published: 2019
Includes: Supplemental data